8-K - Kinnate BioPharma Inc. | Modeledge

Kinnate BioPharma Inc.

Filing type: 8-K
Filing date: Feb 29, 2024
Updated: Mar 1, 2024 · 1:50 AM

Filing

8-KNotice of Exempt Offering of Securities

Exhibits

EX-2.1EXHIBIT 2.1 EX-99.1Notice of Exempt Offering of Securities GRAPHIC GRAPHIC